Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects

Eur J Nucl Med Mol Imaging. 2002 Dec;29(12):1600-7. doi: 10.1007/s00259-002-0972-5. Epub 2002 Sep 21.

Abstract

The aim of this study was to assess regional and global variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects and to evaluate potentially responsible factors. Twenty men with a mean age of 64 years, no history of cardiovascular disease, and normal blood pressure, bicycle exercise test, electrocardiogram and echocardiography were studied [ P(coronary artery disease) <5%]. Whole-body insulin sensitivity and insulin-stimulated myocardial glucose uptake were measured during hyperinsulinaemic euglycaemic glucose clamp with fluorine-18 fluorodeoxyglucose, and myocardial rest and hyperaemic blood flow during dipyridamole infusion were measured with nitrogen-13 ammonia and positron emission tomography in 16 left ventricular myocardial segments. Intra-individual and inter-individual variability of insulin-stimulated myocardial glucose uptake [relative dispersion = (standard deviation/mean)] was 13% and 29% respectively. Although inter-individual variability of glucose uptake and blood flow at rest was of the same magnitude, no correlation was found between these measures. Regional and global insulin-stimulated myocardial glucose uptake correlated linearly with whole-body insulin sensitivity ( r=0.51, P<0.05 and r=0.56, P<0.01). The strongest independent association by multivariate linear regression analysis was found between myocardial glucose uptake and hyperaemic blood flow ( r=0.63, P<0.005). We conclude that in healthy elderly subjects, insulin-stimulated myocardial glucose uptake is homogeneous throughout the left ventricle, but has moderate inter-individual variability. Inter-individual variability of insulin-stimulated myocardial glucose uptake is primarily explained by variability in coronary vascular reactivity and tissue insulin sensitivity.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ammonia / pharmacokinetics
  • Blood Glucose / analysis
  • Dipyridamole
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Glucose / pharmacokinetics*
  • Glucose Clamp Technique / methods
  • Heart Ventricles / diagnostic imaging
  • Heart Ventricles / drug effects*
  • Heart Ventricles / metabolism*
  • Humans
  • Hyperemia / chemically induced
  • Hyperinsulinism / chemically induced
  • Insulin / administration & dosage*
  • Male
  • Middle Aged
  • Nitrogen Radioisotopes / pharmacokinetics
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tissue Distribution
  • Tomography, Emission-Computed / methods*
  • Ventricular Function, Left

Substances

  • Blood Glucose
  • Insulin
  • Nitrogen Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Dipyridamole
  • Ammonia
  • Glucose